Core Viewpoint - A class action lawsuit has been filed against PomDoctor, Ltd. for allegedly making materially false and misleading statements during the class period from October 9, 2025, to December 11, 2025, affecting investors who purchased American Depositary Receipts [1][2] Group 1: Allegations - The complaint alleges that PomDoctor was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [6] - It is claimed that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [6] - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price, rendering their statements about business operations and prospects materially false and misleading [6] Group 2: Legal Process - Investors have until April 6, 2026, to seek appointments as lead plaintiff in the class action lawsuit [1][2] - The law firm Wolf Haldenstein Adler Freeman & Herz LLP, with over 125 years of experience in securities litigation, is leading the case and encourages affected investors to come forward [4]
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately